|
 |
|
| |
|
Newsletter Sponsor
|
|
How will GLP-1 analogs transform the pharma landscape?
GLP-1 analogs have emerged as promising obesity therapies, and oral formulations represent a groundbreaking advancement with the potential to improve patient adherence and expand the therapeutic market. However, their successful implementation faces obstacles such as ensuring stability and optimizing bioavailability for effective delivery. Join our upcoming webinar to learn about the innovative strategies that could overcome these obstacles and reshape the future of obesity management.
 |
|
|
|
|
|
|
|
|
|
 |
Featured Video |
 |
|
| |
|
|
|
A Solid Dosage Future
In the pharmaceutical manufacturing space, while biopharmaceuticals often dominate discussions, it's crucial to acknowledge the enduring significance of solid dosage products (e.g., tablets, capsules,...
read more » |
 |
|
|
|
|
|
 |
| |
|
|
|
|
More Services
|
|
|
|
|
Analytical Methods Development Learn More
Drug Development & Discovery Services Learn More
Formulation & Preformulation Services Learn More
|
|
|
|
|
|
|
Events
|
|
|
|
| |
|
|
|
AAPS 2024 PharmSci 360
Salt Lake City, UT – 10/20/2024
AAPS PharmSci 360 delivers research from across the pharmaceutical continuum. Thousands of scientists from across the globe converge to discuss ...
event details » |
|
|
|
|
|
|
CPHI Worldwide 2024
Fiera Milano, Italy – 10/08/2024
With 62,000 attendees, CPHI Milan is the largest gathering in the pharma industry. We help you to discover, plan and connect with the community to ...
event details » |
|
|
|
 |
|
|
